Expression of dopamine-associated genes on conjunctiva stromal-derived human mesenchymal stem cells

Biochemical and Biophysical Research Communications

Volumn 377, Issue 2, 2008, Pages 423-428

  Nadri, Samad ^a,b   Soleimani, Masoud ^c   Mobarra, Zahra ^a   Amini, Sepideh ^a  

^a Stem Cell Technology Institute   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TARBIAT MODARES UNIVERSITY   (Iran)

Author keywords

Conjunctiva mesenchymal stem cells; Dopamine neuron; Parkinson's diseases

Indexed keywords

BUCLADESINE; DOPAMINE; ISOBUTYLMETHYLXANTHINE; MICROTUBULE ASSOCIATED PROTEIN 2; NUCLEAR RECEPTOR RELATED FACTOR 1; PENTRAXIN 3; RETINOIC ACID; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CONJUNCTIVA; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; MESENCHYMAL STEM CELL; PARKINSON DISEASE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA CELL;

CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SEPARATION; CONJUNCTIVA; DOPAMINE; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STEM CELLS; NEURONS; PARKINSON DISEASE; STROMAL CELLS;

EID: 55549141140     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2008.09.148     Document Type: Article

References (36)

1. Bjarkam C.R., Sorensen J.C., Sunde N.A., Geneser F.A., and Ostergaard K. New strategies for the treatment of Parkinson's disease hold considerable promise for the future management of neurodegenerative disorders. Biogerontology 2 (2001) 193-207
2. Kleiner-Fisman G., Fisman D.N., Sime E., Saint-Cyr J.A., Lozano A.M., and Lang A.E. Long-term follow up of bilateral deep brain stimulation of the subthalamic nucleus in patients with advanced Parkinson disease. J. Neurosurg. 99 (2003) 489-495
3. Fuchs E., and Segre J.A. Stem cells: a new lease on life. Cell 100 (2000) 143-155
4. Buytaert-Hoefen K.A., Alvarez E., and Freed C.R. Generation of tyrosine hydroxylase positive neurons from human embryonic stem cells after coculture with cellular substrates and exposure to GDNF. Stem Cells 22 (2004) 669-674
5. Park C.H., Minn Y.K., Lee J.Y., Choi D.H., Chang M.Y., Shim J.W., Ko J.Y., Koh H.C., Kang M.J., Kang J.S., Rhie D.J., Lee Y.S., Son H., Moon S.Y., Kim K.S., and Lee S.H. In vitro and in vivo analyses of human embryonic stem cell-derived dopamine neurons. J. Neurochem. 92 (2005) 1265-1276
6. Perrier A.L., Tabar V., Barberi T., Rubio M.E., Bruses J., Topf N., Harrison N.L., and Studer L. Derivation of midbrain dopamine neurons from human embryonic stem cells. Proc. Natl. Acad. Sci. USA 101 (2004) 12543-12548
7. Yan Y., Yang D., Zarnowska E.D., Du Z., Werbel B., Valliere C., Pearce R.A., Thomson J.A., and Zhang S.C. Directed differentiation of dopaminergic neuronal subtypes from human embryonic stem cells. Stem Cells 23 (2005) 781-790
8. Zeng X., Cai J., Chen J., Luo Y., You Z.B., Fotter E., Wang Y., Harvey B., Miura T., Backman C., Chen G.J., Rao M.S., and Freed W.J. Dopaminergic differentiation of human embryonic stem cells. Stem Cells 22 (2004) 925-940
9. Roy N.S., Cleren C., Singh S.K., Yang L., Beal M.F., and Goldman S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat. Med. 12 (2006) 1259-1268
10. Lie D.C., Dziewczapolski G., Willhoite A.R., Kaspar B.K., Shults C.W., and Gage F.H. The adult substantia nigra contains progenitor cells with neurogenic potential. J. Neurosci. 22 (2002) 6639-6649
11. Snyder B.J., and Olanow C.W. Stem cell treatment for Parkinson's disease: an update for 2005. Curr. Opin. Neurol. 18 (2005) 376-385
12. Alhadlaq A., and Mao J.J. Mesenchymal stem cells: isolation and therapeutics. Stem Cells Dev. 13 (2004) 436-448
13. Barry F.P. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res. C Embryo Today 69 (2003) 250-256
14. Caplan A.I., and Bruder S.P. Mesenchymal stem cells: building blocks for molecular medicine in the 21st century. Trends Mol. Med. 7 (2001) 259-264
15. Phinney D.G., and Isakova I. Plasticity and therapeutic potential of mesenchymal stem cells in the nervous system. Curr. Pharm. Des. 11 (2005) 1255-1265
16. Bianco P., Riminucci M., Gronthos S., and Robey P.G. Bone marrow stromal stem cells: nature, biology, and potential applications. Stem Cells 19 (2001) 180-192
17. Giordano A., Galderisi U., and Marino I.R. From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells. J. Cell Physiol. 211 (2007) 27-35
18. Schwarz E.J., Alexander G.M., Prockop D.J., and Azizi S.A. Multipotential marrow stromal cells transduced to produce L-DOPA: engraftment in a rat model of Parkinson disease. Hum. Gene Ther. 10 (1999) 2539-2549
19. Nadri S., Soleimani M., Kiani J., Atashi A., and Izadpanah R. Multipotent mesenchymal stem cells from adult human eye conjunctiva stromal cells. Differentiation 76 (2008) 223-231
20. Cotzias G.C., Van Woert M.H., and Schiffer L.M. Aromatic amino acids and modification of parkinsonism. N. Engl. J. Med. 276 (1967) 374-379
21. Olanow C.W., and Tatton W.G. Etiology and pathogenesis of Parkinson's disease. Annu. Rev. Neurosci. 22 (1999) 123-144
22. Bjorklund A., and Lindvall O. Cell replacement therapies for central nervous system disorders. Nat. Neurosci. 3 (2000) 537-544
23. Reubinoff B.E., Itsykson P., Turetsky T., Pera M.F., Reinhartz E., Itzik A., and Ben-Hur T. Neural progenitors from human embryonic stem cells. Nat. Biotechnol. 19 (2001) 1134-1140
24. Zhang S.C., Wernig M., Duncan I.D., Brustle O., and Thomson J.A. In vitro differentiation of transplantable neural precursors from human embryonic stem cells. Nat. Biotechnol. 19 (2001) 1129-1133
25. Kan I., Ben-Zur T., Barhum Y., Levy Y.S., Burstein A., Charlow T., Bulvik S., Melamed E., and Offen D. Dopaminergic differentiation of human mesenchymal stem cells-utilization of bioassay for tyrosine hydroxylase expression. Neurosci. Lett. 419 (2007) 28-33
26. Zuk P.A., Zhu M., Ashjian P., De Ugarte D.A., Huang J.I., Mizuno H., Alfonso Z.C., Fraser J.K., Benhaim P., and Hedrick M.H. Human adipose tissue is a source of multipotent stem cells. Mol. Biol. Cell 13 (2002) 4279-4295
27. Fu Y.S., Cheng Y.C., Lin M.Y., Cheng H., Chu P.M., Chou S.C., Shih Y.H., Ko M.H., and Sung M.S. Conversion of human umbilical cord mesenchymal stem cells in Wharton's jelly to dopaminergic neurons in vitro: potential therapeutic application for Parkinsonism. Stem Cells 24 (2006) 115-124
28. Dezawa M., Kanno H., Hoshino M., Cho H., Matsumoto N., Itokazu Y., Tajima N., Yamada H., Sawada H., Ishikawa H., Mimura T., Kitada M., Suzuki Y., and Ide C. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J. Clin. Invest. 113 (2004) 1701-1710
29. Blondheim N.R., Levy Y.S., Ben-Zur T., Burshtein A., Cherlow T., Kan I., Barzilai R., Bahat-Stromza M., Barhum Y., Bulvik S., Melamed E., and Offen D. Human mesenchymal stem cells express neural genes, suggesting a neural predisposition. Stem Cells Dev. 15 (2006) 141-164
30. Hermann A., Gastl R., Liebau S., Popa M.O., Fiedler J., Boehm B.O., Maisel M., Lerche H., Schwarz J., Brenner R., and Storch A. Efficient generation of neural stem cell-like cells from adult human bone marrow stromal cells. J. Cell Sci. 117 (2004) 4411-4422
31. Bjorklund A. Neurobiology. Better cells for brain repair. Nature 362 (1993) 414-415
32. Chu Y., Kompoliti K., Cochran E.J., Mufson E.J., and Kordower J.H. Age-related decreases in Nurr1 immunoreactivity in the human substantia nigra. J. Comp. Neurol. 450 (2002) 203-214
33. Chu Y., Le W., Kompoliti K., Jankovic J., Mufson E.J., and Kordower J.H. Nurr1 in Parkinson's disease and related disorders. J. Comp. Neurol. 494 (2006) 495-514
34. Castelo-Branco G., Wagner J., Rodriguez F.J., Kele J., Sousa K., Rawal N., Pasolli H.A., Fuchs E., Kitajewski J., and Arenas E. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a. Proc. Natl. Acad. Sci. USA 100 (2003) 12747-12752
35. Martinat C., Bacci J.J., Leete T., Kim J., Vanti W.B., Newman A.H., Cha J.H., Gether U., Wang H., and Abeliovich A. Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype. Proc. Natl. Acad. Sci. USA 103 (2006) 2874-2879
36. Simon H.H., Saueressig H., Wurst W., Goulding M.D., and O'Leary D.D. Fate of midbrain dopaminergic neurons controlled by the engrailed genes. J. Neurosci. 21 (2001) 3126-3134